Noninvasive detection of pancreatic ductal adenocarcinoma using the methylation signature of circulating tumour DNA | BMC Medicine | Full Text
Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)☆ - ESMO Open
Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early Detection - ScienceDirect
CA19-9 - Wikipedia
CA19-9 - Wikipedia
Tumor markers in pancreatic cancer: 2013. | Semantic Scholar
Common benign HPB conditions with associated deranged CA19.9 level | Download Table
Dynamic change of serum CA19–9 levels in benign and malignant patients with obstructive jaundice after biliary drainage and new correction formulas | BMC Cancer | Full Text
The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology
Table 1 from Cancer antigens 19-9 and 125 in the differential diagnosis of pancreatic mass lesions. | Semantic Scholar
Cureus | Infection Masquerading as Recurrence of Pancreatic Ductal Adenocarcinoma: A Cautionary Tale | Article
Old Dog, New Tricks: Use of CA 19-9 for Early Diagnosis of Pancreatic Cancer - Gastroenterology
Tumor Marker:- Part 7 - CA 125 and CA 19-9 - Labpedia.net
Carbohydrate antigen 19-9 — tumor marker: Past, present, and future
Change in CA 19-9 levels after chemoradiotherapy predicts survival in patients with locally advanced unresectable pancreatic cancer - Yang - Journal of Gastrointestinal Oncology
CA 19-9 Antigen - an overview | ScienceDirect Topics
The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice | Science
Non-malignant causes of CA19.9 elevation (medline research) | Download Table
CA19-9 and CA242 as tumor markers for the diagnosis of pancreatic cancer: a meta-analysis | SpringerLink
False-positive rates of CEA according to level (N=597) | Download Scientific Diagram
Frontiers | Diagnostic Significance of Serum IgG Galactosylation in CA19-9- Negative Pancreatic Carcinoma Patients
Non-malignant causes of CA19.9 elevation (medline research) | Download Table
Clinical characteristics and outcomes in carbohydrate antigen 19-9 negative pancreatic cancer
The Highest Ever Reported Level of Carbohydrate Antigen 19-9: A Case Report | Al-Khallaf | Journal of Medical Cases
Serum CA 19-9 and CA 125 as a diagnostic marker in carcinoma of gallbladder Bind MK, Mishra RR, Kumar V, Misra V, Singh PA - Indian J Pathol Microbiol
Trajectories of Perioperative Serum Tumor Markers and Colorectal Cancer Outcomes: A Retrospective, Multicenter Longitudinal Cohort Study - eBioMedicine
